JP2015522652A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015522652A5 JP2015522652A5 JP2015523620A JP2015523620A JP2015522652A5 JP 2015522652 A5 JP2015522652 A5 JP 2015522652A5 JP 2015523620 A JP2015523620 A JP 2015523620A JP 2015523620 A JP2015523620 A JP 2015523620A JP 2015522652 A5 JP2015522652 A5 JP 2015522652A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- pharmaceutically acceptable
- acceptable excipient
- granule fraction
- excipient component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 25
- 238000009472 formulation Methods 0.000 claims 23
- 239000008187 granular material Substances 0.000 claims 22
- 239000000546 pharmaceutic aid Substances 0.000 claims 15
- 239000002518 antifoaming agent Substances 0.000 claims 8
- 239000003085 diluting agent Substances 0.000 claims 8
- 239000003795 chemical substances by application Substances 0.000 claims 7
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims 6
- 239000003159 antacid agent Substances 0.000 claims 4
- 230000001458 anti-acid Effects 0.000 claims 4
- 239000011230 binding agent Substances 0.000 claims 4
- 150000007524 organic acids Chemical class 0.000 claims 4
- 239000003381 stabilizer Substances 0.000 claims 4
- 229960005077 Sodium Picosulfate Drugs 0.000 claims 3
- GOZDTZWAMGHLDY-UHFFFAOYSA-L Sodium picosulfate Chemical compound [Na+].[Na+].C1=CC(OS(=O)(=O)[O-])=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OS([O-])(=O)=O)C=C1 GOZDTZWAMGHLDY-UHFFFAOYSA-L 0.000 claims 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 3
- 229960005070 ascorbic acid Drugs 0.000 claims 3
- 235000010323 ascorbic acid Nutrition 0.000 claims 3
- 239000011668 ascorbic acid Substances 0.000 claims 3
- 239000000395 magnesium oxide Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 229940093915 Gynecological Organic acids Drugs 0.000 claims 2
- 229940023488 Pill Drugs 0.000 claims 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N Simethicone Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims 2
- 229940083037 Simethicone Drugs 0.000 claims 2
- 230000000181 anti-adherence Effects 0.000 claims 2
- 239000003911 antiadherent Substances 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 238000010790 dilution Methods 0.000 claims 2
- 239000007884 disintegrant Substances 0.000 claims 2
- 238000007654 immersion Methods 0.000 claims 2
- 230000001050 lubricating Effects 0.000 claims 2
- 235000005985 organic acids Nutrition 0.000 claims 2
- 230000003204 osmotic Effects 0.000 claims 2
- 239000006187 pill Substances 0.000 claims 2
- WSVLPVUVIUVCRA-RJMJUYIDSA-N (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol;hydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-RJMJUYIDSA-N 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 230000036826 Excretion Effects 0.000 claims 1
- 229960001021 Lactose Monohydrate Drugs 0.000 claims 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 230000000112 colonic Effects 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 230000002708 enhancing Effects 0.000 claims 1
- 230000029142 excretion Effects 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- -1 fatty acid ester Chemical class 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 238000005461 lubrication Methods 0.000 claims 1
- 229960000869 magnesium oxide Drugs 0.000 claims 1
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 1
- 239000008108 microcrystalline cellulose Substances 0.000 claims 1
- 229910052755 nonmetal Inorganic materials 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000001737 promoting Effects 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 229960002920 sorbitol Drugs 0.000 claims 1
Claims (24)
- (i)少なくとも一の浸透圧排出促進剤、少なくとも一の制酸剤および第一の薬剤的に許容可能な賦形剤成分を、内部顆粒画分を形成するために湿式造粒すること;
(ii)工程(i)で得られた該内部顆粒画分を、一又は複数の有機酸、非金属の潤滑成分および第二の薬剤的に許容可能な賦形剤成分を含む外部顆粒画分の成分と混合すること;ならびに
(iii)工程(ii)で得られた該混合物を錠剤に圧縮すること、を含む固形投与製剤の製造方法。 - (iv)該錠剤を被覆すること、をさらに含む、請求項1の方法。
- 該内部顆粒画分が該製剤の総重量の約50%を構成し、かつ該外部顆粒画分が該製剤の総重量の約50%を構成する、請求項1の方法。
- 該第一の薬剤的に許容可能な該賦形剤成分が、結合剤、希釈剤、安定剤、崩壊剤、消泡剤、抗粘着剤または消泡剤の少なくとも一つを含有する、請求項1の方法。
- 該第二の薬剤的に許容可能な該賦形剤成分が、結合剤、希釈剤、安定剤、崩壊剤、消泡剤、抗粘着剤または消泡剤の少なくとも一つを含有する、請求項1の方法。
- 該製剤中の希釈剤が、該内部顆粒画分と該外部顆粒画分との間で均等に分割されるように、該第一の薬剤的に許容可能な該賦形剤成分が、希釈剤の第一の量を含有し、かつ該第二の薬剤的に許容可能な該賦形剤成分が、同じ希釈剤の第二の量を含有する、請求項1の方法。
- 該内部顆粒画分の該少なくとも一つの浸透圧排出促進剤成分が該製剤の総重量の1%までを構成する、請求項1の方法。
- 該内部顆粒画分の該少なくとも一つの制酸剤成分が該製剤の総重量の20%までを構成する、請求項1の方法。
- 該第一の薬剤的に許容可能な該賦形剤成分が該製剤の総重量の30%までを構成する、請求項1の方法。
- 該外部顆粒画分の該一または複数の有機酸が該製剤の総重量の40%までを構成する、請求項1の方法。
- 該外部顆粒画分の該非金属の潤滑成分が該製剤の総重量の3%までを構成する、請求項1の方法。
- 該第二の薬剤的に許容可能な賦形剤成分が該製剤の総重量の10%までを構成する、請求項1の方法。
- 外部顆粒画分と混合された内部顆粒画分を含む固形投与製剤であって、ここで該内部顆粒画分が少なくとも一の浸透圧排出促進剤、少なくとも一の制酸剤および第一の薬剤的に許容可能な賦形剤成分を含む顆粒を含有し、かつここで該外部顆粒画分が一または複数の有機酸、非金属の潤滑成分および第二の薬剤的に許容可能な賦形剤成分を含有する前記投与製剤。
- 該内部顆粒画分が該製剤の総重量の約50%を構成し、かつ該外部顆粒画分が該製剤の総重量の約50%を構成する、請求項13の製剤。
- 該少なくとも一の浸透圧排出促進剤が微粉化ピコスルファートナトリウムである、請求項13の製剤。
- 該少なくとも一の制酸剤が酸化マグネシウムである、請求項13の製剤。
- 該少なくとも一の有機酸がアスコルビン酸である、請求項13の製剤。
- 該非金属の潤滑剤が脂肪酸エステルである、請求項13の製剤。
- 該第一の薬剤的に許容可能な賦形剤成分が結合剤、希釈剤、安定剤、崩壊剤、消泡剤、抗粘着剤または消泡剤の少なくとも一つを含有する、請求項13の製剤。
- 該第二の薬剤的に許容可能な賦形剤成分が結合剤、希釈剤、安定剤、崩壊剤、消泡剤、抗粘着剤または消泡剤の少なくとも一つを含有する、請求項13の製剤。
- 該製剤中の希釈剤が該内部顆粒画分と該外部顆粒画分の間に均等に分割されるように、該第一の薬剤的に許容可能な賦形剤成分が希釈剤の第一の量を含有し、かつ該第二の薬剤的に許容可能な賦形剤成分が同じ該希釈剤の第二の量を含有する、請求項13の製剤。
- 該希釈剤がラクトース一水和物、微結晶セルロースもしくはソルビトールのひとつまたは組み合せより選択される、請求項21の製剤。
- 錠剤、カプセル、トローチ、丸薬;または二層錠剤、二層カプセル、二層トローチもしくは二層丸薬の形態である、請求項13の製剤。
- 患者の結腸排出促進のための錠剤形態の医薬組成物であって、外部顆粒画分と混合された内部顆粒画分を含有し、
ここで該内部顆粒画分がピコスルファートナトリウム、酸化マグネシウム、シメチコン、および第一の薬剤的に許容可能な賦形剤成分を含む顆粒を含有し、該外部顆粒画分がアスコルビン酸および第二の薬剤的に許容可能な賦形剤成分を含有し、
該錠剤形態の医薬組成物は、24時間枠以内に、25ないし30個の錠剤を液体と共に患者に経口投与する方法であって、該錠剤を全て併せると、ピコスルファートナトリウム約30mg、酸化マグネシウム約7g、アスコルビン酸約15gおよびシメチコン約100mgの合計投薬量となる方法により投与される、前記医薬組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261676608P | 2012-07-27 | 2012-07-27 | |
US61/676,608 | 2012-07-27 | ||
PCT/IB2013/001640 WO2014016671A2 (en) | 2012-07-27 | 2013-07-26 | Formulations and methods of manufacturing formulations for use in colonic evacuation |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015522652A JP2015522652A (ja) | 2015-08-06 |
JP2015522652A5 true JP2015522652A5 (ja) | 2016-12-01 |
JP6454640B2 JP6454640B2 (ja) | 2019-01-16 |
Family
ID=49997911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015523620A Active JP6454640B2 (ja) | 2012-07-27 | 2013-07-26 | 結腸排出促進における使用のための製剤および製剤製造方法 |
Country Status (25)
Country | Link |
---|---|
US (3) | US10166219B2 (ja) |
EP (1) | EP2877163B1 (ja) |
JP (1) | JP6454640B2 (ja) |
KR (1) | KR102152873B1 (ja) |
CN (2) | CN104797244B (ja) |
AU (1) | AU2013294737B2 (ja) |
BR (1) | BR112015001640A2 (ja) |
CA (1) | CA2880282C (ja) |
CY (1) | CY1121852T1 (ja) |
DK (1) | DK2877163T3 (ja) |
ES (1) | ES2717282T3 (ja) |
HK (1) | HK1212596A1 (ja) |
HR (1) | HRP20190550T1 (ja) |
HU (1) | HUE043852T2 (ja) |
IL (1) | IL236791B (ja) |
IN (1) | IN2015DN00637A (ja) |
MX (1) | MX366707B (ja) |
NZ (1) | NZ704014A (ja) |
PH (1) | PH12015500165A1 (ja) |
PL (1) | PL2877163T3 (ja) |
PT (1) | PT2877163T (ja) |
RU (1) | RU2015106688A (ja) |
SI (1) | SI2877163T1 (ja) |
TR (1) | TR201904884T4 (ja) |
WO (1) | WO2014016671A2 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103338768B (zh) | 2010-12-13 | 2019-04-19 | 萨利克斯药品有限公司 | 胃和结肠的配制剂及其制备和使用方法 |
TR201904884T4 (tr) | 2012-07-27 | 2019-05-21 | Redhill Biopharma Ltd | Koloni̇k boşaltmada kullanima yöneli̇k formülasyonlar ve formülasyonlarin üreti̇m yöntemleri̇ |
IN2013MU02911A (ja) * | 2013-09-10 | 2015-07-03 | Cadila Healthcare Ltd | |
KR101420315B1 (ko) | 2014-03-19 | 2014-07-17 | 남봉길 | 약학적 액제 조성물 |
MX2018001965A (es) | 2015-08-17 | 2018-11-09 | Ferring Bv | Formulaciones liquidas que contienen picosulfato y citrato de magnesio. |
TW201804996A (zh) * | 2016-07-08 | 2018-02-16 | 輝凌責任有限公司 | 含有匹可硫酸鹽(picosulfate)之安定液體調配物 |
EP3345591A1 (en) * | 2017-01-06 | 2018-07-11 | Oystershell NV | Oral dosage form for enhanced solubilization of a poorly soluble active agent and method of preparation |
Family Cites Families (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3459863A (en) | 1966-10-14 | 1969-08-05 | Merck & Co Inc | Color-stable ascorbic acid tablet |
US4186025A (en) | 1975-09-25 | 1980-01-29 | Merck & Co., Inc. | Aqueous polysaccharide composition |
US4452779A (en) | 1982-02-03 | 1984-06-05 | Cockerill Vernon | Composition and method of treating lactating mammals |
DK454683D0 (da) | 1983-10-03 | 1983-10-03 | Mogens Gjerloev | Tarmreguleringsmiddel til behandling af diarre hos dyr samt anvendelse heraf |
WO1986005981A1 (en) | 1985-04-18 | 1986-10-23 | Borody Thomas J | Treatment of non-ulcer dyspepsia with bismuth salts |
US4766004A (en) | 1986-12-19 | 1988-08-23 | Warner-Lambert Company | Crunchy, highly palatable, bulk-increasing, dietary fiber supplement composition |
IL86859A (en) | 1987-07-10 | 1991-12-15 | E Z Em Inc | Aqueous cathartic solution containing inorganic salts |
DE3887353T2 (de) | 1987-10-12 | 1994-05-05 | Exomed Australia Pty Ltd | Behandlungsverfahren für magen-darm-krankheiten. |
WO1989005659A1 (en) | 1987-12-24 | 1989-06-29 | Borody Thomas J | Orthostatic lavage solutions |
ATE165738T1 (de) | 1988-08-02 | 1998-05-15 | Gastro Services Pty Ltd | Behandlung von gastro-intestinalen krankheiten |
US5443826A (en) | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
US5213807A (en) | 1990-05-03 | 1993-05-25 | Chemburkar Pramod B | Pharmaceutical composition containing ibuprofen and a prostaglandin |
US5232699A (en) | 1990-07-26 | 1993-08-03 | The Proctor & Gamble Company | Laxative compositions |
US5519014A (en) | 1990-10-22 | 1996-05-21 | Borody; Thomas J. | Treatment of non-inflammatory and non-infectious bowel disorders |
DE69133348T3 (de) | 1990-10-22 | 2011-05-12 | Centre for Digestive Diseases Pty, Ltd. | Behandlung von nicht-entzündlichen darmerkrankungen |
US5173296A (en) | 1990-11-16 | 1992-12-22 | The Procter & Gamble Company | Compositions containing psyllium |
JPH06132767A (ja) | 1992-10-22 | 1994-05-13 | Rohm Co Ltd | 圧電発振子 |
DK0686034T3 (da) * | 1993-02-26 | 2001-08-27 | Procter & Gamble | Bisacodyl-doseringsform |
JP2974550B2 (ja) * | 1993-06-01 | 1999-11-10 | ビオフェルミン製薬株式会社 | 経口投与用固体組成物 |
AU7961094A (en) * | 1993-10-19 | 1995-05-08 | Procter & Gamble Company, The | Picosulphate dosage form |
JP3850891B2 (ja) | 1994-03-01 | 2006-11-29 | ゼリア新薬工業株式会社 | 緩下効果を有する組成物 |
AUPM695294A0 (en) | 1994-07-20 | 1994-08-11 | Borody, Thomas Julius | Improved combination therapy dose unit |
AUPM864894A0 (en) | 1994-10-07 | 1994-11-03 | Borody, Thomas Julius | Treatment of bowel-dependent neurological disorders |
RU2098100C1 (ru) | 1995-10-11 | 1997-12-10 | Максимова Ирина Сергеевна | Ирригационный раствор для офтальмологических операций |
US6103268A (en) | 1995-11-03 | 2000-08-15 | Borody; Thomas Julius | Administering osmotic colonic evacuant containing a picosulfate |
NZ333493A (en) | 1995-11-03 | 2000-06-23 | Nicolas Peter Shortis | Method of evacuating a patient's colon by oral administration of an osmotic colonic evacuant in powder form |
AUPN634595A0 (en) | 1995-11-03 | 1995-11-30 | Borody, Thomas Julius | Improved method for colonic evacuation |
AU771576B2 (en) | 1995-11-03 | 2004-03-25 | Red Hill Biopharma Ltd. | Improved preparation for colonic evacuation |
US6087386A (en) | 1996-06-24 | 2000-07-11 | Merck & Co., Inc. | Composition of enalapril and losartan |
RU2189227C2 (ru) * | 1996-07-12 | 2002-09-20 | Дайити Фармасьютикал Ко., Лтд. | Быстро распадающиеся прессованные в формах материалы и способ их получения |
US5948787A (en) | 1997-02-28 | 1999-09-07 | Alza Corporation | Compositions containing opiate analgesics |
US6162464A (en) | 1997-03-31 | 2000-12-19 | Inkine Pharmaceutical, Inc. | Non-aqueous colonic purgative formulations |
US6551632B2 (en) | 1997-04-01 | 2003-04-22 | Thomas Julius Borody | Methods and compositions for treating inflammatory bowel disease |
JP2001524951A (ja) | 1997-04-01 | 2001-12-04 | トーマス ジュリアス ボロディー | 炎症性腸疾患を治療するための方法および組成物 |
CN1252711A (zh) | 1997-04-18 | 2000-05-10 | 大正制药株式会社 | 微乳 |
AUPO665397A0 (en) | 1997-05-07 | 1997-05-29 | Borody, Thomas Julius | Novel therapy for constipation |
AR016827A1 (es) | 1997-08-22 | 2001-08-01 | Smithkline Beecham Corp | PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA |
ZA987590B (en) * | 1997-08-22 | 1999-02-22 | Smithkline Beecham Corp | Rapidly disintegrating methylcellulose tablets |
AR017512A1 (es) * | 1997-08-22 | 2001-09-12 | Smithkline Beecham Corp | Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas |
JP4092748B2 (ja) | 1997-09-05 | 2008-05-28 | ニプロ株式会社 | 腸管洗浄液 |
US5843477A (en) * | 1997-09-30 | 1998-12-01 | Bayer Corporation | Lubricants for use in tabletting |
WO1999032092A1 (en) * | 1997-12-19 | 1999-07-01 | Smithkline Beecham Corporation | Process for manufacturing bite-dispersion tablets |
AUPP325398A0 (en) | 1998-04-30 | 1998-05-21 | Borody, Thomas J. | Improved method for eradicating h. pylori |
AUPP437698A0 (en) | 1998-06-30 | 1998-07-23 | Baumgart, Karl | Methods for treatment of coronary, carotid and other vascular disease |
EP1005863A1 (en) | 1998-12-04 | 2000-06-07 | Synthelabo | Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof |
US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
CN1183904C (zh) | 1999-02-26 | 2005-01-12 | 盐野义制药株式会社 | 改进了服用性的咀嚼型软胶囊剂及其制法 |
US6858403B2 (en) | 1999-05-11 | 2005-02-22 | M-Biotech, Inc. | Polymer matrix containing catalase co-immobilized with analytic enzyme that generates hydrogen peroxide |
DE19930030B4 (de) | 1999-06-30 | 2004-02-19 | Meduna Arzneimittel Gmbh | CO-3-ungesättigte Fettsäuren enthaltende orale Darreichungsform |
CN1288730A (zh) * | 1999-09-07 | 2001-03-28 | 麦克内尔-Ppc股份有限公司 | 轻泻组合物 |
US6774111B1 (en) | 2000-03-14 | 2004-08-10 | Abbott Laboratories | Carbohydrate system and a method for providing nutrition to a diabetic |
BR0110208A (pt) | 2000-04-19 | 2003-01-28 | Borody Thomas J | Composições e terapias para distúrbios associados com hiperlipidemia |
CN1444484A (zh) | 2000-06-19 | 2003-09-24 | 穆科普罗泰科有限公司 | 用益生菌对粘膜表面的细菌或病毒感染进行治疗或免疫治疗及用于此的组合物 |
AUPQ854100A0 (en) | 2000-07-03 | 2000-07-27 | Helirad Pty Ltd | Methods for monitoring treatment of helicobacter infection |
AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
MXPA03007678A (es) | 2001-02-27 | 2004-03-16 | Ranbaxy Lab Ltd | Composicion farmaceutica oral de proxetil cefpodoxima. |
ATE354969T1 (de) | 2001-03-13 | 2006-03-15 | Kellog Co | Belüftete nahrungsmittelkomponente |
US6790453B2 (en) | 2001-03-14 | 2004-09-14 | Mccormick & Company, Inc. | Encapsulation compositions and process for preparing the same |
US7815956B2 (en) | 2001-04-27 | 2010-10-19 | Pepsico | Use of erythritol and D-tagatose in diet or reduced-calorie beverages and food products |
EA006398B1 (ru) | 2001-06-01 | 2005-12-29 | Поузен Инк. | Фармацевтические композиции для координированной доставки нестероидных противовоспалительных лекарственных средств |
CN100366239C (zh) | 2001-07-05 | 2008-02-06 | 涌永制药株式会社 | 软胶囊剂 |
US20030092724A1 (en) | 2001-09-18 | 2003-05-15 | Huaihung Kao | Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic |
AUPS017702A0 (en) | 2002-01-25 | 2002-02-14 | Atopic Pty Ltd | Methods and compositions for the treatment of asthma and related disorders |
AUPS088702A0 (en) | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
US6753009B2 (en) | 2002-03-13 | 2004-06-22 | Mcneil-Ppc, Inc. | Soft tablet containing high molecular weight polyethylene oxide |
EP2425821B1 (en) | 2002-04-05 | 2017-05-10 | Euro-Celtique S.A. | Pharmaceutical preparation containing oxycodone and naloxone |
US6946149B2 (en) | 2002-04-30 | 2005-09-20 | Braintree Laboratories, Inc. | Salt solution for colon cleansing |
JP4591742B2 (ja) * | 2003-01-06 | 2010-12-01 | 大正製薬株式会社 | ジオクチルソジウムスルホサクシネート配合製剤およびその製造方法 |
AU2003900553A0 (en) | 2003-02-10 | 2003-02-20 | Borody, Thomas Julius | Novel Improved Method for Detection of Dientamoeba fragilis and other Parasites |
WO2004091665A1 (en) | 2003-04-08 | 2004-10-28 | Progenics Pharmaceuticals, Inc. | Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist |
US7749533B2 (en) | 2003-05-07 | 2010-07-06 | Akina, Inc. | Highly plastic granules for making fast melting tablets |
WO2005000237A2 (en) | 2003-06-25 | 2005-01-06 | University Of Tennessee Research Foundation | Granules containing biologically active substances |
US7687075B2 (en) | 2003-11-19 | 2010-03-30 | Salix Pharmaceuticals, Ltd. | Colonic purgative composition with soluble binding agent |
JP2005255595A (ja) * | 2004-03-10 | 2005-09-22 | Taisho Pharmaceut Co Ltd | ジオクチルソジウムスルホサクシネート配合錠剤 |
JP2005272401A (ja) * | 2004-03-25 | 2005-10-06 | Tendou Seiyaku Kk | チュアブル錠 |
UA86802C2 (ru) | 2004-04-13 | 2009-05-25 | Бёрингер Ингельхайм Интернациональ Гмбх | Комбинация симетикона и бисакодила для предрасположенных к запору пациентов, которые страдают от ощущения вздутия живота |
KR100749229B1 (ko) | 2005-04-29 | 2007-08-13 | (주)아모레퍼시픽 | 당 및 당알콜을 함유하는 변비개선용 조성물 |
US20060275223A1 (en) | 2005-06-02 | 2006-12-07 | Burr James B | Erythritol compositions for teeth and gums |
DE102006033014A1 (de) | 2005-09-13 | 2007-04-05 | Volkswagen Ag | Eingabevorrichtung für ein Kraftfahrzeug |
WO2007057924A1 (en) | 2005-11-21 | 2007-05-24 | Panacea Biotec Ltd | Laxative composition on the basis of triphala |
CA2635313C (en) | 2005-12-29 | 2013-12-31 | Osmotica Corp. | Triple combination release multi-layered tablet |
JP5006567B2 (ja) | 2006-04-14 | 2012-08-22 | 花王株式会社 | 口腔用固形製剤 |
WO2008014175A2 (en) | 2006-07-28 | 2008-01-31 | Dr. Reddy's Laboratories Ltd. | Granular pharmaceutical compositions |
WO2008021394A2 (en) | 2006-08-15 | 2008-02-21 | Theraquest Biosciences, Llc | Pharmaceutical formulations of cannabinoids and method of use |
WO2008027442A2 (en) | 2006-08-30 | 2008-03-06 | Theraquest Biosciences, Llc | Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use |
CA2668867C (en) | 2006-12-04 | 2013-09-10 | E. I. Dupont De Nemours And Company | Acrylic polyol coating composition |
AU2008253583A1 (en) | 2007-05-17 | 2008-11-27 | David Lubowski | Combination laxative compositions comprising a colonic stimulant and a bulking laxative |
CA2687192C (en) | 2007-06-04 | 2015-11-24 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
CN101707930B (zh) | 2007-06-06 | 2013-10-30 | 巴斯夫欧洲公司 | 用于制备快速崩解的片剂的药物配制剂 |
CN101686931B (zh) | 2007-06-06 | 2013-06-19 | 巴斯夫欧洲公司 | 用于制备可咀嚼片剂和锭剂的药物配制剂 |
EP2264042B1 (en) | 2007-07-27 | 2012-07-18 | Cargill, Incorporated | Micronization of polyols |
JP5537943B2 (ja) | 2007-09-27 | 2014-07-02 | 田辺三菱製薬株式会社 | 速崩壊性固形製剤 |
KR101626873B1 (ko) | 2007-10-01 | 2016-06-02 | 라보라토리오스 레스비, 에스.엘. | 구강붕해정제 |
KR101381263B1 (ko) * | 2007-10-12 | 2014-04-04 | 페링 인터내셔널 센터 에스 에이 | 구연산, 산화 마그네슘, 중탄산칼륨 및 피코황산나트륨을 포함하는 의약품의 제조 방법, 이러한 방법에 의해 제조된 과립을 포함하는 약제학적 조성물 및 중간체 |
CN101406457A (zh) * | 2007-10-12 | 2009-04-15 | 辉凌国际制药(瑞士)有限公司 | 制备药物产品的方法 |
US20100222311A1 (en) | 2007-10-19 | 2010-09-02 | Purdue Research Foundation | Solid formulations of crystalline compounds |
JP5258268B2 (ja) | 2007-11-19 | 2013-08-07 | フロイント産業株式会社 | 球形粒の製造方法 |
US20090155363A1 (en) | 2007-12-14 | 2009-06-18 | Todd Maibach | Methods for oral administration of active drugs |
US20090169622A1 (en) * | 2007-12-27 | 2009-07-02 | Roxane Laboratories, Inc. | Delayed-release oral pharmaceutical composition for treatment of colonic disorders |
EP2233129B1 (en) | 2007-12-28 | 2014-05-07 | Sawai Pharmaceutical Co., Ltd. | Oral cavity disintegrating tablet and method of producing the same |
US20090258090A1 (en) | 2008-04-11 | 2009-10-15 | Braintree Laboratories, Inc. | Colon cleansing solution |
US20100178413A1 (en) | 2008-12-17 | 2010-07-15 | Mark Gorris | Food-based Supplement Delivery System |
US20100285164A1 (en) | 2009-05-11 | 2010-11-11 | Jrs Pharma | Orally Disintegrating Excipient |
WO2010138439A1 (en) | 2009-05-28 | 2010-12-02 | Aptapharma, Inc. | Multiparticulate controlled-release selective serotonin reuptake inhibitor formulations |
JP2011019046A (ja) | 2009-07-08 | 2011-01-27 | Nec Commun Syst Ltd | 通信制御装置、通信制御方法、プログラム、及び記録媒体 |
JP5674666B2 (ja) * | 2009-08-11 | 2015-02-25 | 富士化学工業株式会社 | 崩壊性粒子組成物及び口腔内速崩壊錠 |
US8900602B2 (en) * | 2009-08-11 | 2014-12-02 | Fuji Chemical Industry Co., Ltd. | Disintegrating particle composition and orally rapidly disintegrating tablet |
JP5663238B2 (ja) * | 2009-08-31 | 2015-02-04 | ライオン株式会社 | 内服固形製剤及びその製造方法 |
JP2011157348A (ja) * | 2010-01-05 | 2011-08-18 | Fuji Chem Ind Co Ltd | 崩壊性高強度球状粒子組成物 |
JP5711520B2 (ja) | 2010-01-06 | 2015-04-30 | 三洋化成工業株式会社 | 外用組成物 |
US20110218216A1 (en) | 2010-01-29 | 2011-09-08 | Kumaravel Vivek | Extended release pharmaceutical composition of donepezil |
JP2012079118A (ja) | 2010-10-01 | 2012-04-19 | Toyota Motor Corp | 走行支援装置及び方法 |
CN103338768B (zh) | 2010-12-13 | 2019-04-19 | 萨利克斯药品有限公司 | 胃和结肠的配制剂及其制备和使用方法 |
EP2782581A4 (en) | 2011-10-27 | 2015-05-20 | Salix Pharmaceuticals Inc | ELEKTROLYT laxatives |
TR201904884T4 (tr) | 2012-07-27 | 2019-05-21 | Redhill Biopharma Ltd | Koloni̇k boşaltmada kullanima yöneli̇k formülasyonlar ve formülasyonlarin üreti̇m yöntemleri̇ |
WO2014032108A1 (en) | 2012-08-29 | 2014-03-06 | Borody Thomas J | Laxative compositions and methods for treating constipation and related gastrointestinal diseases and conditions |
-
2013
- 2013-07-26 TR TR2019/04884T patent/TR201904884T4/tr unknown
- 2013-07-26 IN IN637DEN2015 patent/IN2015DN00637A/en unknown
- 2013-07-26 ES ES13822195T patent/ES2717282T3/es active Active
- 2013-07-26 DK DK13822195.7T patent/DK2877163T3/en active
- 2013-07-26 JP JP2015523620A patent/JP6454640B2/ja active Active
- 2013-07-26 US US14/417,172 patent/US10166219B2/en active Active
- 2013-07-26 KR KR1020157004752A patent/KR102152873B1/ko active IP Right Grant
- 2013-07-26 WO PCT/IB2013/001640 patent/WO2014016671A2/en active Application Filing
- 2013-07-26 NZ NZ704014A patent/NZ704014A/en unknown
- 2013-07-26 CA CA2880282A patent/CA2880282C/en active Active
- 2013-07-26 SI SI201331432T patent/SI2877163T1/sl unknown
- 2013-07-26 AU AU2013294737A patent/AU2013294737B2/en active Active
- 2013-07-26 EP EP13822195.7A patent/EP2877163B1/en active Active
- 2013-07-26 CN CN201380049674.4A patent/CN104797244B/zh active Active
- 2013-07-26 HU HUE13822195A patent/HUE043852T2/hu unknown
- 2013-07-26 RU RU2015106688A patent/RU2015106688A/ru unknown
- 2013-07-26 MX MX2015000971A patent/MX366707B/es active IP Right Grant
- 2013-07-26 BR BR112015001640A patent/BR112015001640A2/pt active Search and Examination
- 2013-07-26 CN CN201810101389.7A patent/CN108175773A/zh active Pending
- 2013-07-26 PL PL13822195T patent/PL2877163T3/pl unknown
- 2013-07-26 PT PT13822195T patent/PT2877163T/pt unknown
-
2015
- 2015-01-19 IL IL236791A patent/IL236791B/en active IP Right Grant
- 2015-01-26 PH PH12015500165A patent/PH12015500165A1/en unknown
-
2016
- 2016-01-15 HK HK16100483.6A patent/HK1212596A1/zh not_active IP Right Cessation
-
2018
- 2018-11-13 US US16/189,847 patent/US10493065B2/en not_active Expired - Fee Related
-
2019
- 2019-03-20 HR HRP20190550TT patent/HRP20190550T1/hr unknown
- 2019-03-26 CY CY20191100344T patent/CY1121852T1/el unknown
- 2019-10-25 US US16/663,652 patent/US11058671B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2015522652A5 (ja) | ||
HRP20190550T1 (hr) | Formule i metode proizvodnje formulacija za upotrebu u pražnjenju debelog crijeva | |
HRP20161262T1 (hr) | Tablete ulipristal acetata | |
TWI700100B (zh) | 用於口服投藥之包含依澤替米貝(ezetimibe)及羅舒伐他汀(rosuvastatin)的複合調配物及其製備方法 | |
JP2006104221A5 (ja) | ||
JP2013509395A5 (ja) | ||
HRP20240034T1 (hr) | Liječenje kardiovaskularnih bolesti | |
JP2012236834A5 (ja) | ||
JP2015510916A5 (ja) | ||
RU2015100905A (ru) | Сухой порошок для ингаляционного препарата, включающий сальметерола ксинафоат, флутиказона пропионат и тиотропия бромид, а также способ его изготовления | |
CN104434931A (zh) | 含替格瑞洛和阿司匹林的复方口服固体剂及其制备方法 | |
JP2019218379A5 (ja) | ||
HRP20192227T1 (hr) | Dvojna uporaba oralnog farmaceutskog pripravka tableta sulfatnih soli i metode njihove uporabe | |
RU2016117186A (ru) | Комбинированная композиция, содержащая тадалафил и амлодипин | |
US20110142944A1 (en) | Andrographis extract formulations | |
RU2015129714A (ru) | Композиция в форме таблеток, содержащая гидрохлорид цинакалцета | |
KR101801064B1 (ko) | 위장질환 치료용 삼중층 정제 | |
RU2014146936A (ru) | Композиции с немедленным высвобождением лекарственного средства | |
CN104069085A (zh) | 一种阿司匹林肠溶缓释胶囊及其制备方法 | |
TW201416072A (zh) | 經安定化的內服用固形製劑 | |
JP6838474B2 (ja) | 固形組成物 | |
RU2009121838A (ru) | Пероральная лекарственая форма, содержащая соединения тризамещенного глицерина | |
JP2010509293A5 (ja) | ||
JP2007077116A (ja) | 臓器線維化抑制剤 | |
CN105878200A (zh) | 一种盐酸曲美他嗪缓释片及其制备方法 |